UNITED CAPITAL FINANCIAL ADVISORS, LLC
Position in IMMX — Immix Biopharma, Inc.
CIK 1463217
IRVING, TX
Position in IMMX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$728,731
+$84,818 QoQ
Shares Held
70,682
0.0% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#48
of 108 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IMMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $15,880,894 across 17 Biotechnology names. IMMX ranks #8 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,438 | $6,178,327 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,651 | $1,653,004 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,155 | $1,250,779 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
13,677 | $1,070,498 | |
| 5 | MRNA |
Moderna, Inc.
|
13,077 | $915,782 | |
| 6 | CBUS |
Cibus, Inc.
|
576,043 | $789,178 | |
| 7 | INCY |
Incyte Corp
|
6,876 | $779,463 | |
| 8 | IMMX |
Immix Biopharma, Inc.
This page
|
70,682 | $728,731 |
All Filings in IMMX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $728,731 | 70,682 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $643,913 | 70,682 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $369,666 | 70,682 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $147,725 | 70,682 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||